Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Equity (2016 - 2025)

Historic Return on Equity for Aytu Biopharma (AYTU) over the last 17 years, with Q4 2025 value amounting to 0.01%.

  • Aytu Biopharma's Return on Equity rose 500.0% to 0.01% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.01%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.03% for FY2025, which is 1300.0% up from last year.
  • Aytu Biopharma's Return on Equity amounted to 0.01% in Q4 2025, which was up 500.0% from 0.01% recorded in Q3 2025.
  • In the past 5 years, Aytu Biopharma's Return on Equity ranged from a high of 0.02% in Q2 2025 and a low of 2.06% during Q2 2022
  • In the last 5 years, Aytu Biopharma's Return on Equity had a median value of 0.39% in 2021 and averaged 0.57%.
  • As far as peak fluctuations go, Aytu Biopharma's Return on Equity plummeted by -16500bps in 2022, and later skyrocketed by 16400bps in 2023.
  • Aytu Biopharma's Return on Equity (Quarter) stood at 0.77% in 2021, then crashed by -112bps to 1.63% in 2022, then surged by 79bps to 0.35% in 2023, then skyrocketed by 87bps to 0.04% in 2024, then soared by 114bps to 0.01% in 2025.
  • Its Return on Equity was 0.01% in Q4 2025, compared to 0.01% in Q3 2025 and 0.02% in Q2 2025.